Advertisements

Stocking Stuffers

 

Advaxis Inc. (ADXS) Stock Quote

Detailed Quote for Advaxis Inc. (ADXS)
$ 0.313   -0.012 (-3.69%) Volume: 4.73m 4:00 PM EDT Oct 16, 2019
After Hours:  $ 0.31   -0.003 (-0.96%) Volume: 120.88k 7:57 PM EDT Oct 16, 2019
Today 5d 1m 3m 1y more
Last Price
0.313
Change $
0.012
Change %
3.69%
Tick
  
Bid
0.296
Bid Size
10,000
Ask
0.30
Ask Size
16,200
Open
0.315
High
0.3249
Low
0.302
Prev Close
0.325
Last Trade
10/16/19
Volume
4.73m
52 Wk Hi
10.8000001
52 Wk Low
0.205099999
Market Cap
7.73m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
24,710,135
EPS (TTM)
-4.26000022
PE Ratio
N/A
Exchange
NGS
News and Media for Advaxis Inc. (ADXS)
Sector News | Topic News
News for Advaxis Inc. (ADXS)
Thu, Oct 10, 2019
8:00 AM Advaxis and UCLA Enter Collaboration for Glioblastoma Immunotherapy Discovery Research - Business Wire
Mon, Oct 07, 2019
8:00 AM Advaxis Announces Updated Prolonged Survival Data in Phase 1/2 ADXS-PSA Trial - Business Wire
Mon, Sep 09, 2019
8:12 AM Advaxis reports Q3 results - SeekingAlpha
8:00 AM Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update - Business Wire
Thu, Aug 22, 2019
8:00 AM Advaxis, Inc. Issues Letter to Shareholders - Business Wire
Mon, Aug 12, 2019
6:30 AM BriaCell Appoints Richard J. Berman to Board of Directors - GlobeNewswire
Thu, Jul 25, 2019
11:30 AM Advaxis, Inc. Announces Closing of $17 Million Public Offering and Exercise in Full of the Underwriters' Over-Allotment Option - Business Wire
Tue, Jul 23, 2019
9:58 AM Advaxis prices equity offering; shares down 27% - SeekingAlpha
8:30 AM Advaxis, Inc. Announces Pricing of $16 Million Public Offering - Business Wire
Mon, Jul 22, 2019
12:32 PM Microcaps mostly among midday movers - SeekingAlpha
Mon, Jul 15, 2019
9:12 AM UEC, ADXS among premarket gainers - SeekingAlpha
8:00 AM New Immune Data from Ongoing ADXS-NEO Phase 1 Study Support Clinical Potential for Neoantigen-Directed Immunotherapies - Business Wire
Wed, Jul 03, 2019
11:24 AM NIO, SYMC and USNA among midday movers - SeekingAlpha
Tue, Jul 02, 2019
5:41 PM Advaxis -6.9% as it files for capital raise - SeekingAlpha
5:31 PM TSLA, ENDP and NOG among notable after hour movers - SeekingAlpha
Thu, Jun 27, 2019
6:50 AM Advaxis Announces Increasing Focus on Neoantigen-Directed Immunotherapies and Closing of Its Phase 3 AIM2CERV Study - Business Wire
Mon, Jun 17, 2019
12:43 PM BID, ARRY, BHVN and EBIX among notable midday movers - SeekingAlpha
Tue, Jun 11, 2019
2:53 PM Advaxis, Inc. (ADXS) CEO Kenneth Berlin on Q2 2019 Results - Earnings Call Transcript - SeekingAlpha
More News for ADXS >>
Filings for Advaxis Inc. (ADXS)
Fri, Oct 04, 2019
3:00 AM Current report pursuant to Section 13 or 15(d) - Form 8-K
Thu, Jun 27, 2019
3:00 AM Current report pursuant to Section 13 or 15(d) - Form 8-K
More Filings for ADXS >>

Tags for Advaxis Inc.

Research stocks or mutual funds related to Advaxis Inc. by keywords or tags. Find companies that have a similar focus to ADXS. The keywords below have been associated to ADXS by either user submission or electronic means.

intellectual property law group Commercial Physical And Biological Research (8731) intellectual property guidelines patent licence Biological Products intellectual property technology intellectual property consultants china property law corporate governance practices selling intellectual property report on corporate governance corporate governance issues corporate directors patent protection t cell positive board of directors role t cell clones board of directors governance board governance role of the board of directors Drugs listeria meningitis intellectual property law patents laws valuing intellectual property duties of directors board of directors compensation patent violation board of directors responsibility intellectual property forum Healthcare corporate governance best practices listeria monocytogenes corporate governance board of directors board of directors fees intellectual property litigation t cell lines dendritic cell intellectual property assignment company board of directors intellectual property rights china board of directors report Except Diagnostic Substances (2836) Common Stock liability of directors corporate governance policies cell production china intellectual property corporate board of directors corporate governance report